Aug. 12 2025
Source Page: Pharmacy Quality Scheme 2025/26: antimicrobial stewardship clinical audit – sore throat consultationsAug. 07 2025
Source Page: Policy on working in partnership with people and communitiesAug. 06 2025
Source Page: Betula verrucosa for treating moderate to severe allergic rhinitis or conjunctivitis caused by tree pollenAug. 06 2025
Source Page: Ribociclib with an aromatase inhibitor for adjuvant treatment of hormone receptor-positive HER2-negative early breast cancer at high risk of recurrenceAug. 06 2025
Source Page: Ribociclib with an aromatase inhibitor for adjuvant treatment of hormone receptor-positive HER2-negative early breast cancer at high risk of recurrenceAug. 06 2025
Source Page: Independent Patient Choice and Procurement Panel: case acceptance decision in relation to a proposed contract award for intermediate minor oral surgery services, Yorkshire and HumberAug. 06 2025
Source Page: Ribociclib with an aromatase inhibitor for adjuvant treatment of hormone receptor-positive HER2-negative early breast cancer at high risk of recurrenceAug. 06 2025
Source Page: Ribociclib with an aromatase inhibitor for adjuvant treatment of hormone receptor-positive HER2-negative early breast cancer at high risk of recurrenceAug. 06 2025
Source Page: Ribociclib with an aromatase inhibitor for adjuvant treatment of hormone receptor-positive HER2-negative early breast cancer at high risk of recurrenceAug. 06 2025
Source Page: Betula verrucosa for treating moderate to severe allergic rhinitis or conjunctivitis caused by tree pollen